Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (624)

« Back to Publications

Evolution and significance of neuronal surface autoantibodies after Japanese encephalitis

Nibber A. et al, (2025), Journal of Neuroimmunology, 406, 578671 - 578671

Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial.

Idro R. et al, (2024), Lancet Glob Health, 12, e1149 - e1158

IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation.

Cao M. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10

Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients.

Nagaoka A. et al, (2022), J Neurol Sci, 443

Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts

Wood GK. et al, (2022), BMJ Neurology Open, 4, e000323 - e000323

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis

Damato V. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, 995 - 1000

Using AChR antibody titres to predict treatment responses in myasthenia gravis.

Vincent A., (2021), J Neurol Neurosurg Psychiatry, 92

Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.

Coutinho E. et al, (2021), Neurol Neuroimmunol Neuroinflamm, 8

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

Pollak TA. et al, (2021), Molecular Psychiatry, 26, 2590 - 2604

Neuronal surface antibodies are common in children with narcolepsy and active movement disorders.

Giannoccaro MP. et al, (2020), J Neurol Neurosurg Psychiatry

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.

Cetin H. et al, (2020), J Neurol Neurosurg Psychiatry, 91, 526 - 532

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.

Huda S. et al, (2020), Neurol Neuroimmunol Neuroinflamm, 7

Myasthenia gravis

Gilhus NE. et al, (2019), Nature Reviews Disease Primers, 5

Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravis

Takata K. et al, (2018)

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia

Vincent A. et al, (2018), JAMA Neurology, 75, 1519 - 1519

Load More

1
2
3
4
5
6
7
...
»